tiprankstipranks
Blonder Tongue Laboratories (BDRL)
OTHER OTC:BDRL
US Market

Blonder Tongue Laboratories (BDRL) Financial Statements

204 Followers

Blonder Tongue Laboratories Financial Overview

Blonder Tongue Laboratories's market cap is currently ―. The company's EPS TTM is $-0.152; its P/E ratio is -0.72; Blonder Tongue Laboratories is scheduled to report earnings on November 15, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 5.28M$ 5.26M$ 4.23M$ 3.34M$ 3.99M
Gross Profit$ 2.06M$ 1.41M$ 1.06M$ 939.00K$ 1.37M
EBIT$ 236.00K$ -475.00K$ -962.00K$ -1.02M$ -777.00K
EBITDA$ 437.00K$ -229.00K$ -713.00K$ -764.00K$ -486.00K
Net Income Common Stockholders$ 144.00K$ -703.00K$ -1.15M$ -1.15M$ -927.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 79.00K$ 167.00K$ 361.00K$ 110.00K$ 274.00K
Total Assets$ 14.93M$ 15.28M$ 12.30M$ 11.53M$ 11.91M
Total Debt$ 10.80M$ 10.82M$ 6.99M$ 5.42M$ 5.86M
Net Debt$ 10.72M$ 10.65M$ 6.63M$ 5.31M$ 5.59M
Total Liabilities$ 13.77M$ 14.34M$ 10.83M$ 9.12M$ 8.63M
Stockholders Equity$ 1.07M$ 937.00K$ 1.47M$ 2.41M$ 3.29M
Cash Flow-
Free Cash Flow$ 197.00K$ -238.00K$ -1.47M$ 74.00K$ -559.00K
Operating Cash Flow$ 210.00K$ -220.00K$ -1.45M$ 78.00K$ -540.00K
Investing Cash Flow$ -13.00K$ -18.00K$ -20.00K$ -4.00K$ -19.00K
Financing Cash Flow$ -285.00K$ 44.00K$ 1.72M$ -238.00K$ 562.00K
Currency in USD

Blonder Tongue Laboratories Earnings and Revenue History

Blonder Tongue Laboratories Debt to Assets

Blonder Tongue Laboratories Cash Flow

Blonder Tongue Laboratories Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis